This work is licensed under a Table 1.
Results of tests describing the significance of differences in the control and polycystic ovary syndrome groups.
| CON | PCOS | P-value | |
|---|---|---|---|
| M (±s.d.) | M (±s.d.) | ||
| Anthropometric parameters | |||
| Age | 27.12 (4.97) | 26.34 (5.47) | 0.14 |
| Body mass (kg) | 64.47 (14.65) | 70.39 (16.41) | 0.001 |
| Height (cm) | 166.83 (6.45) | 166.33 (5.84) | 0.43 |
| BMI (kg/m2) | 23.14 (4.93) | 25.46 (5.91) | <0.001 |
| WC (cm) | 77.06 (13.21) | 82.03 (13.86) | <0.001 |
| WHtR | 0.46 (.09) | 0.49 (.09) | <0.001 |
| SBP | 118.95 (11.50) | 119.49 (12.69) | 0.90 |
| DBP | 74.32 (9.75) | 74.95 (8.93) | 0.95 |
| Biochemical parameters | |||
| TC (mg/dL) | 168.18 (28.00) | 172.56 (34.02) | 0.73 |
| LDL-C (mg/dL) | 89.07 (29.67) | 92.35 (37.14) | 0.91 |
| TG (mg/dL) | 79.27 (27.88) | 94.36 (61.75) | 0.54 |
| HDL-C (mg/dL) | 63.45 (12.81) | 63.73 (16.29) | 0.84 |
| Glucose (mg/dL) | 88.94 (7.62) | 90.17 (18.09) | 0.95 |
| Insulin (mIU/mL) | 10.86 (7.41) | 11.41 (8.22) | 0.93 |
| HOMA-IR | 2.47 (1.87) | 2.76 (3.62) | 0.83 |
| Hormonal parameters | |||
| FSH (mIU/mL) | 5.23 (2.21) | 5.97 (2.00) | 0.01 |
| LH (mIU/mL) | 7.81 (7.03) | 11.38 (8.34) | <0.001 |
| DHEAS (µg/dL) | 289.72 (105.36) | 325.51 (134.92) | 0.12 |
| E2 (pg/mL) | 81.28 (66.45) | 64.72 (62.99 | 0.10 |
| T (nmol/L) | 1.28 (.58) | 1.77 (.73) | <0.001 |
| SHBG (nmol/L) | 75.30 (51.66) | 61.71 (36.70) | 0.31 |
| FTI (%) | 2.49 (1.95) | 4.06 (3.45) | <0.001 |
| TSH (mIU/mL) | 2.12 (1.23) | 2.16 (1.19) | 0.65 |
| AMH (pmol/L) | 3.50 (1.22) | 9.21 (5.74) | <0.001 |
| Psychological characteristics | |||
| SSQ total score | 31.48 (6.22) | 31.43 (6.24) | 0.94 |
| Depressive symptoms | 14.44 (11.93) | 13.39 (10.63) | 0.62 |
| WHO QoL physical health | 21.23 (3.37) | 21.15 (3.09) | 0.81 |
| WHO QoL psychological health | 21.00 (3.07) | 20.43 (3.15) | 0.08 |
| WHO QoL social relationships | 7.78 (1.61) | 7.80 (1.46) | 0.66 |
| WHO QoL environment | 29.77 (3.90) | 29.58 (4.37) | 0.08 |
| WHO QoL WHO question 1 | 4.05 (0.66) | 4.00 (0.64) | 0.42 |
| WHO QoL WHO question 2 | 3.69 (0.84) | 3.30 (0.86) | <0.001 |
AMH, anti-Müllerian hormone; CON, control subjects; DBP, diastolic blood pressure;, ; E2, estradiol; FSH, follicle-stimulating hormone; FTI, free testosterone index; HDL, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment for insulin resistance index; LDL-C, low-density lipoprotein cholesterol; LH, luteinizing hormone; M (±s.d.), mean ± standard deviation; PCOS, polycystic ovary syndrome patients; QoL, quality of life; SBP, systolic blood pressure; SHBG, sex hormone-binding globulin; SSQ, sexual satisfaction questionnaire; T, total testosterone; TC, total cholesterol; TG, triglycerides; TG/HDL-C, the ratio of triglycerides to HDL-cholesterol; TSH, thyroid-stimulating hormone; WC, waist circumference; WHtR, waist-to-height ratio.